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Stem Cell TransplantationIt was the best of times, it was the worst of times, it was
the age of wisdom, it was the age of foolishness.
Charles Dickens – A Tale of Two Cities (1859)
This (admittedly somewhat worn-out) quote came to
mind while perusing the contributions included in the
2008 Educational Supplement on Hematopoietic Cell Trans-
plantation, which accompanies the 2008 BMT Tandem
Meetings of theCenter for International Blood andMar-
row Transplant Research (CIBMTR) and the American
Society for Blood and Marrow Transplantation.
The twenty chapters cover a variety of topics in he-
matopoietic stem cell transplantation, demonstrating
the strong underpinning of clinical strategies by basic
research, and the integration of the latest research in di-
verse areas ranging from immunotherapy to regenera-
tive medicine. The chapters are written by a diverse
group of experts and cover recent advances in the
biology and clinical use of hematopoietic stem cell
transplantation, including immunology (graft-versus-
leukemia, memory T cells, immune reconstitution, T
cell therapy, immunotherapy, vaccination), particular
diseases (amyloidosis, mantle cell lymphoma, T cell
lymphoma, large cell lymphoma, acute leukemia, pedi-
atric cancers, SCID), (cancer) stem cell biology (cancer
stem cells), clinical trials (CIBMTR/EBMT key stud-ies), transplant-related complications (chronic
GVHD, graft failure, late effects, kidney disease, oral
disease), umbilical cord blood transplantation, phar-
macogenomics, mouse models, regenerative medicine,
and alternative donor sources.
After reading these chapters, I am sure that the
reader will agree that it is truly the best of times in
transplant medicine, which is well positioned to take
advantage of the exciting progress in stem cell biology,
cancer biology, oncology, immunotherapy, regenera-
tive medicine and other disciplines to design curative
therapies for patients with life-threatening diseases.
And although the current crisis in NIH funding and
the political hurdles for stem cell research might feel
like the worst of times, this collection of contributions
from basic and clinical scientists is a testimony of the
vitality and great promise of our field.
I want to thank all the authors and editors for their
contributions and, in particular, Alan Leahigh and
Robert Krawisz, who organized and produced this
Educational Supplement.
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